Evidence map›Paper›PMID 33984086›Full record

ArticleJournal of medical cases2020

COVID-19 Pneumonia or Hypereosinophilic Syndrome?

Istemi Serin, Avni Ulusoy, Mediha Irem Onar, Mehmet Hilmi Dogu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Present and future: Infectious tropical travel rashes and the impact of climate change.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Istemi SerinDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Avni UlusoyDepartment of Internal Medicine, University of Health Sciences, Bagcilar Training and Research Hospital, Bagcilar, Istanbul, Turkey.
Mediha Irem OnarDepartment of Internal Medicine, University of Health Sciences, Bagcilar Training and Research Hospital, Bagcilar, Istanbul, Turkey.
Mehmet Hilmi DoguDeparment of Internal Medicine and Hematology, Liv Hospital ULUS, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypereosinophilic syndromes (HESs) are a group of disorders characterized by pathological proliferation of eosinophils. Diagnostic criteria include eosinophil count of 1,500/mm

Indexed as

COVID-19EosinophiliaHypereosinophilic syndromePulmonary involvement

Identifiers

PMID33984086
PMCPMC8040447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.